SEARCH RESULTS FOR: "Tag: ZYNE"
REFINE YOUR SEARCH:
RECENT
Last Week(1)
Last Month(1)
ARTICLES/BLOGS
2019(4)
2018(1)
2017(6)
2015(1)
CATEGORIES
Buzz Stocks(4)
Intraday Option Activity(1)
Opening View(4)
Stock Market News(2)
Stocks On the Move(2)

9/18/2019 9:16 AM
Dow Jones Industrial Average (DJI) futures are trading cautiously below fair value ahead of this afternoon's Federal Open Market Committee (FOMC) policy decision and subsequent press conference fr...
6/11/2019 9:16 AM
The Dow Jones Industrial Average (DJI) is yet again set for a positive open, with futures trading more than 100 points above fair value. Another win would be a seventh straight for the index, whi...
5/6/2019 12:11 PM
The Food and Drug Administration (FDA) granted Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) "fast track" status for its cannabinoid-based gel, Zygel, used in the treatment of symptoms brought on by the ...
2/26/2019 9:31 AM
The shares of Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) are soaring in electronic trading trading, last seen up 15.3%. Boosting the stock is news the drug name received a U.S. patent for its cannabid...
7/5/2018 9:11 AM
Shares of drug concern Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) have plunged in pre-market trading, after the company reported top line results for a Phase 1 trial of its ZYN001 tetrahydrocannabino...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center